Lupin has declared its fourth quarter results. Kamal K Sharma, MD, Lupin says, the company’s endeavour would be to grow around 25% year-on-year (YoY) on organic basis, unless it makes some inorganic moves that could be additive. “Our attempt has always been to improve on EBITDA margins by atleast 75 bps,” he adds.
first published: May 12, 2011 04:27 pm
A collection of the most-viewed Moneycontrol videos.
Groww CEO Lalit Keshre on ₹62,000 Crore IPO, Sebi regulations, valuation expectation and more
How Income Plus Arbitrage Fund of Fund Can Help You Get Stable, Tax-Efficient Returns
Nifty fails to hold 26,000, slips below 25,900 | Closing Bell
Live: Will Nifty bulls take it to new highs after Fed outcome? | Opening Bell
